000046460 000__ 00961nam\a2200337\i\4500
000046460 001__ 46460
000046460 003__ SzGeWIPO
000046460 005__ 20240708150244.0
000046460 006__ m\\\\eo\\d\\\\\\\\
000046460 007__ cr bn |||m|||a
000046460 008__ 220628s2021\\\\enk\\\\\o\\\\\000\0\eng\d
000046460 022__ $$a0018-9855
000046460 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000046460 041__ $$aeng
000046460 24500 $$aGermany: "INJEKT/INJEX"
000046460 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2021
000046460 300__ $$a1 online resource
000046460 337__ $$acomputer$$2rdamedia
000046460 4901_ $$aInternational Review of Intellectual Property Law & Competition Law,$$vVolume 52,
000046460 4901_ $$xIssue 5 ;
000046460 542__ $$fhttps://1.next.westlaw.com/Copyright
000046460 588__ $$aCrossref
000046460 590__ $$aPublished online: 2021
000046460 650_0 $$aIntellectual property
000046460 650_0 $$aTrademarks$$zGermany
000046460 650_0 $$aHealth
000046460 650_0 $$aInfringment
000046460 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000046460 7731_ $$wIIC
000046460 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vIIC 2021, 52(5), 655-667
000046460 85641 $$uhttps://www.westlaw.com/Document/IE19437F0CA4A11EBA9EBF3A4BA8ABDE4/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046460 904__ $$aJournal article
000046460 980__ $$aIIC